<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00347893</url>
  </required_header>
  <id_info>
    <org_study_id>22222</org_study_id>
    <nct_id>NCT00347893</nct_id>
  </id_info>
  <brief_title>The Efficacy of Selective Laser Trabeculoplasty</brief_title>
  <official_title>Clinical Results of Selective Laser Trabeculoplasty in Treatment of Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glaucoma Research &amp; Education Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PharmaLogic Development, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Glaucoma Research &amp; Education Group</source>
  <brief_summary>
    <textblock>
      Selective laser trabeculoplasty (SLT) is a new method to reduce intraocular pressure in eyes
      with open angle glaucoma or ocular hypertension. SLT may also be effective for cases with
      previously failed ALT procedures. We will study the efficacy and safety of the SLT procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Selective laser trabeculoplasty (SLT) has been shown to be a safe, well tolerated, and
      effective intraocular pressure reduction therapy for several forms of open-angle glaucoma.
      SLT produces significantly less disturbance to the trabecular meshwork and is theoretically
      more repeatable than the ALT procedure. This retrospective research will begin with cases
      treated in 2001. It will evaluate whether SLT is effective for patients who have had prior
      treatment with ALT and it will determine whether the IOP lowering effect is sustainable over
      time. It will also assess the efficacy of repeated SLT procedures.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Retrospective</time_perspective>
  </study_design_info>
  <condition>Primary Open Angle Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <condition>Pseudo-Exfoliative Glaucoma</condition>
  <condition>Pigment Dispersion Glaucoma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Selective laser trabeculoplasty</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with primary open angle glaucoma, ocular hypertension, pseudo exfoliative
             glaucoma, pigment dispersion glaucoma

        Exclusion Criteria:

          -  History of prior invasive glaucoma surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew G. Iwach, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glaucoma Research &amp; Education Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glaucoma Center of San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha T Klufas, OD</last_name>
      <phone>415-986-0835</phone>
      <email>martha@glaucomagroup.org</email>
    </contact>
    <investigator>
      <last_name>Andew G. Iwach, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jing Ming Shi, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Terri Pickering, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2006</study_first_submitted>
  <study_first_submitted_qc>June 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2006</study_first_posted>
  <last_update_submitted>June 30, 2006</last_update_submitted>
  <last_update_submitted_qc>June 30, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2006</last_update_posted>
  <keyword>Primary open angle glaucoma</keyword>
  <keyword>Ocular hypertension</keyword>
  <keyword>Pseudo-exfoliative glaucoma</keyword>
  <keyword>Pigment Dispersion glaucoma</keyword>
  <keyword>selective laser trabeculoplasty</keyword>
  <keyword>intraocular pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

